BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study
A Prospective, Double-Blind Evaluation of the Effects of BioCleanse Tibialis Tendon Allograft and Donor Age on Clinical Outcomes of ACL Reconstruction
Sponsor: RTI Surgical
Listed as NCT00975845, this observational or N/A phase trial focuses on Anterior Cruciate Ligament Rupture and remains completed. Sponsored by RTI Surgical, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Completed
-
Sep 2018 — Apr 2019 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- RTI Surgical
For direct contact, visit the study record on ClinicalTrials.gov .